The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.842
Bid: 0.842
Ask: 0.852
Change: 0.002 (0.24%)
Spread: 0.01 (1.188%)
Open: 0.84
High: 0.842
Low: 0.84
Prev. Close: 0.84
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

15 Feb 2018 16:30

RNS Number : 0526F
BioPharma Credit PLC
15 February 2018
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

BioPharma Credit Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

No

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

Placing of Shares

Yes

3. Full name of person(s) subject to thenotification obligation:

Invesco Limited

4. Full name of shareholder(s) (if different from 3.):

 

5. Date of the transaction and date onwhich the threshold is crossed orreached:

30 March 2017

6. Date on which issuer notified:

31 March 2017

7. Threshold(s) that is/are crossed orreached:

5%,10%,11%,12%,13%,14%,15%,16%,17%,18%,19%

      
 

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary Shares

N/A

N/A

 

 

150,000,000

 

19.69%

GB00BDGKMY29

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

150,000,0000

19.69%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

Invesco Asset Management Limited - 150,000,000

 

 

Proxy Voting:

10. Name of the proxy holder:

Invesco Limited

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

 

13. Additional information:

 

14. Contact name:

Philippa Holmes

15. Contact telephone number:

01491 417 447

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUVRNRWUAUAAR
Date   Source Headline
28th Sep 20207:00 amRNSSTATEMENT REGARDING SAREPTA THERAPEUTICS
21st Sep 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
16th Sep 20207:05 amRNSAppointment of New Director
16th Sep 20207:00 amRNSHalf-year Report
9th Sep 20204:00 pmRNSLEXICON PHARMACEUTICALS PREPAYMENT
21st Aug 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Aug 20203:25 pmRNSNotice of Half Year Results
12th Aug 20203:30 pmRNSDividend Declaration
7th Aug 20207:00 amRNSUPDATES TO THE PORTFOLIO
4th Aug 20204:30 pmRNSHolding(s) in Company
4th Aug 202011:15 amRNSHolding(s) in Company
3rd Aug 20201:15 pmRNSTotal Voting Rights
30th Jul 20204:00 pmRNSSTATEMENT REGARDING LEXICON PHARMACEUTICALS
24th Jul 20203:15 pmRNSHolding(s) in Company
21st Jul 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Jul 20207:00 amRNSAMICUS PREPAYMENT
16th Jul 20207:00 amRNSCOMPLETION OF SHARE BUYBACK PROGRAMME
15th Jul 20205:30 pmRNSTransaction in Own Shares
14th Jul 20205:30 pmRNSTransaction in Own Shares
13th Jul 20205:45 pmRNSTransaction in Own Shares
13th Jul 20207:00 amRNSSHARE BUY-BACK PROGRAMME
9th Jul 20205:45 pmRNSDirector/PDMR Shareholding
25th Jun 20203:00 pmRNSResult of AGM
22nd Jun 20207:00 amRNSNet Asset Value(s) and Monthly Factsheet
22nd Jun 20207:00 amRNSActivation of Discount Control Mechanism
19th Jun 20204:30 pmRNSChange of AGM Venue
29th May 20205:30 pmRNSNotice of AGM
28th May 20205:30 pmRNSHolding(s) in Company
26th May 20207:00 amRNSNEW CREDIT FACILITY
22nd May 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
14th May 20203:00 pmRNSDividend Declaration
7th May 20205:30 pmRNSDate of Annual General Meeting
27th Apr 202012:30 pmRNSArticles of Association
23rd Apr 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
22nd Apr 202012:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20205:40 pmRNSHolding(s) in Company
20th Mar 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Mar 20202:00 pmRNSREPLACEMENT: Annual Financial Report
10th Mar 20207:00 amRNSAnnual Financial Report
21st Feb 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Feb 20205:00 pmRNSDividend Declaration
17th Feb 202010:10 amRNSNotice of Full Year Results
7th Feb 20207:00 amRNSNEW INVESTMENT
27th Jan 20204:48 pmRNSHolding(s) in Company
22nd Jan 20204:00 pmRNSNet Asset Value(s)
20th Dec 20194:00 pmRNSNet Asset Value(s)
18th Dec 201912:15 pmRNSNew Investment
13th Dec 20192:01 pmRNSCorrection: New Investment
13th Dec 20191:35 pmRNSNew Investment
12th Dec 20192:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.